Health Care Closes -0.5% as Large Caps Cushion Thin Breadth

On Thursday, September 10, the Health Care Select Sector SPDR Fund (XLV), an exchange-traded fund that tracks the sector, closed -0.5% at $165.67, reflecting a session where 51.0% of the fund's graded weight sits in high-quality companies graded A or B. Breadth inside the sector remained narrow, with only 21.1% of member stocks advancing as the cap-weighted sector closed -0.5%. Larger holdings provided stability against a broader pullback, as the equal-weighted sector finished at -1.0%. Across the wider market, 2 of the 11 sectors rose.

Company-specific earnings updates and product news drove performance across individual industry groups. Sector leadership came from Elevance Health Inc (+4.9%), which rose after reaffirming its full-year adjusted profit floor of at least $27 per share and noting favorable medical cost trends. Additional support came from Biogen Inc (+2.2%), while pharmaceutical heavyweight AbbVie held firm after a late-stage trial showed its migraine therapy met all primary and secondary endpoints.

Conversely, device makers faced steep pressure. The sector's sharpest decline came from The Cooper Companies, Inc (-14.7%), which dropped after missing quarterly revenue expectations and forecasting modest organic growth, compounded by a strategic review that concluded without a sale of its surgical unit. In the health insurance group, Humana saw mixed sentiment after announcing plans to drop roughly 600,000 Medicare Advantage members across underperforming plans.

EasyAlpha grades each company against its industry peers. Companies graded A or B have stronger fundamentals, and historically they have carried a lower risk of large drawdowns than companies graded D or E. With 51.0% of the fund's graded holdings in those top tiers, XLV maintains a solid quality base even during sessions with thin market breadth.

Over intermediate and longer timeframes, the fund has moved +12.4% over the past one hundred sessions, +10.3% over the past six months, and +20.6% over the past twelve months, despite recording -1.4% over the past month. Carrying $43.9 billion in net assets at an expense ratio of 0.08%, the fund cushions single-stock volatility across the wider sector.